Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 91.78 USD -1.71% Market Closed
Market Cap: 4.7B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Haemonetics Corp
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Haemonetics Corp
Net Income (Common) Peer Comparison

Comparables:
XRAY
ICUI
ALGN
LNTH
MMSI

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Haemonetics Corp
NYSE:HAE
Net Income (Common)
$123.8m
CAGR 3-Years
58%
CAGR 5-Years
13%
CAGR 10-Years
15%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Net Income (Common)
-$413m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ICU Medical Inc
NASDAQ:ICUI
Net Income (Common)
-$70.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Net Income (Common)
$441.6m
CAGR 3-Years
-16%
CAGR 5-Years
1%
CAGR 10-Years
12%
Lantheus Holdings Inc
NASDAQ:LNTH
Net Income (Common)
$427.6m
CAGR 3-Years
N/A
CAGR 5-Years
65%
CAGR 10-Years
N/A
Merit Medical Systems Inc
NASDAQ:MMSI
Net Income (Common)
$120m
CAGR 3-Years
40%
CAGR 5-Years
45%
CAGR 10-Years
19%

See Also

What is Haemonetics Corp's Net Income (Common)?
Net Income (Common)
123.8m USD

Based on the financial report for Sep 28, 2024, Haemonetics Corp's Net Income (Common) amounts to 123.8m USD.

What is Haemonetics Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
15%

Over the last year, the Net Income (Common) growth was -3%. The average annual Net Income (Common) growth rates for Haemonetics Corp have been 58% over the past three years , 13% over the past five years , and 15% over the past ten years .

Back to Top